Sun Pharma Advanced Research Company Limited has officially confirmed the completion of share dematerialization processes for the final quarter of the financial year. The company’s registrar, MUFG Intime India Private Limited, verified that all requests for share conversions were processed, validated, and updated in the register of members within the mandated timelines for the quarter ending March 31, 2026.
Quarterly Dematerialization Update
Sun Pharma Advanced Research Company Limited (SPARC) has announced the successful completion of its share dematerialization review for the period ending March 31, 2026 (Q4). This process ensures that all shares converted into electronic form during the quarter are correctly reflected in the records of the depositories, providing shareholders with a seamless transition from physical to digital holdings.
Verification and Compliance
The company’s registrar and share transfer agent, MUFG Intime India Private Limited, has confirmed that all received share certificates were properly processed. This includes the mutilation and cancellation of original certificates following verification, and the subsequent substitution of depository names in the register of members. These administrative actions were completed within the prescribed timelines, ensuring transparency and accuracy for all stakeholders involved in electronic share management.
Source: BSE
